Paragon Care Limited (ASX:PGC)

Market Cap	364.17M
Revenue (ttm)	3.61B
Net Income (ttm)	20.57M
Shares Out	1.66B
EPS (ttm)	0.01
PE Ratio	17.74
Forward PE	10.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,614,190
Average Volume	1,211,686
Open	0.2500
Previous Close	0.2500
Day's Range	0.2200 - 0.2500
52-Week Range	0.2000 - 0.5900
Beta	1.42
RSI	51.08
Earnings Date	Feb 24, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2005
• Employees: 550
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PGC

Financial Performance

In 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.